Date updated:11-19-2007
I hold a number of stocks that I believe could have explosive growth, but many are selling for pennies or less, and they certainly could go out of business.

-
IMGN
Immunogen Inc - $3.95
- -2.71%
- $3.98
I've held this stock essentially since its start in 1990, while it certainly hasn't done what I hoped for, today it has more to offer than ever before. There are currently five drugs in trials, licenses for eight more anticipated in trials over the next few years. More importantly, by August of 2008 SNY should license ten or more new licenses, and several other new licenses are expected. The key is reaching drug approval, and that will take a few years, but when it happens this company's stock could split multiple times because of the number of drugs that are following it.

-
CTKH.PK
Cetek Tech Inc Ne - $0.0001
- 0.00%
- $N/A
Cetek is involved with the specialty ceramics that are involved in all sorts of electronics including flat panel displays. If the information regarding the Cetek Process is true, they've developed ways of producing very high quality thin ceramic films that require little or no machining. Furthermore, if true they also have much shorter processing time then the competition which often has it's products in the ovens for about a week. It's highly speculative, the CEO doesn't properly report quarterly or other results, but appears to be the brilliant genius who developed the process and improve on it. There are over 5 billion shares outstanding, but if earnings are positive, this stock could easily rise to the pennies, instead of being subpenny, percentage wise that would be huge.

-
GNVC
Genvec Inc - $1.01
- -2.88%
- $1.05
A recent acquisition based on a drug that appears headed for approval. I expect rapid appreciation on approval of the drug. I don't see the kind of platform IMGN has, but they do have a platform and I really like platform technologies. They are also working with Homeland Security on a vaccine for foot and mouth disease. It's a strong endorsement of the technology they're developing.

-
CEXI.OB
Cdex Inc Cl A - $0.18
- -10.00%
- $0.18
They have developed unique detectors for validating the correct contents of drugs, and are working on devices that can determine liquor, wines, etc are counterfeit. They also are working on detection of explosives and illegal drugs. They appear to have some unique technologies which if proven could grow rapidly especailly in the current environment. Right now they're struggling to fund development, but growth could be big if someone likes what they see.

-
MDOR.OB
Magnum D Or Resou - $0.79
- 0.00%
- $0.787
Currently in the process of reinventing themselves. Don't know precisely where they'll go but they've moved up substantially since the new CEO came aboard. The mines I originally invested for will apparently be spun of to another new company which investors will receive stock in.

-
APPI.OB
Appi.ob - $0.00
- N/A
- $N/A
Also reinventing themselves in green fuels, but they still hold majority interest in a small drug company. With the anticipated growth in bio-diesel and ethanol fuels this company could be at the right place at the right time. The company's name and symbol are about to change, this too could spur interest in the company.

-
DNDN
Dendreon Corp - $4.67
- -3.51%
- $4.75
I purchased some Feb 7.50 calls as they are extremely low priced and with all the volatility in the stock should offer the opportunity for quick profit. Should the news of either approval or major partnership occur before they expire the stock could easily reach $20 or more permitting me to purchase either all the shares on margin, or most of them by selling a small portion of what I optioned.
- Skitahoe Portfolio 1's Blog
- No Blogs Found
- Top Professional Portfolios
- 1. The Children's Investm...
- 2. Navellier & Associ...
- 3. Joel Greenblatt
- 4. T. Rowe Price New Era ...
- 5. Neuberger Berman Genes...
- show all
- Top Do-It-Yourself Portfolios
- » charcagle Portfolio 1
- » Blank
- » Drew's List
- » Robin Retirement
- » The Eagle's Nest
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » 10 Short Squeezes
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- show all
After a while, even investors get used to the bad news. Thursday started moderately low, a tempered response given all the recent bad news from retailers. But investo...
Jim Cramer continues to find more reasons to be optimistic about the U.S. stock market. Recently, he has noticed that many new developments and changes are beginning to hap...
Part of the philosophy of Stockpickr is to follow in the footsteps of smart people. This could mean a few different things. First, it could mean piggybacking great inve...
Since most hedge funds get paid based on their returns for the year, managers who want to get the most out of a stock investment often turn to shareholder activism as a way...
A. It will be volatile.
A. small trading before thrusday
This portfolio consists of NYSE stocks that are trading for less than $5 per share and are profitable. more
These stocks were upgraded at TheStreet.com Ratings on Nov. 26, 2008. Click here for more information about the ratings' changes.... more
Here are the latest Activist or "13D" situations from the StreetInsider.com 13D Tracker page found at: http://www.13dtracker.blogspot.com/.... more






Comments not available